Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options

Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options

Anti-vascular endothelial growth factor (anti-VEGF) therapy currently plays a central role in the treatment of numerous retinal diseases, most notably exudative age-related macular degeneration (eAMD), diabetic retinopathy and retinal vein occlusions. While offering significant functional and anatom...

Full description

Bibliographic Details
Main Authors:	Josh O. Wallsh, Ron P. Gallemore
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Cells
Subjects:	anti-VEGF macular degeneration diabetic retinopathy resistant retinal vein occlusion
Online Access:	https://www.mdpi.com/2073-4409/10/5/1049

Similar Items

The Dilemma between the Randomized Control Trials and Real Life Practice in the Treatment of Retinal Diseases with Intravitreal anti-VEGF agents
by: Abdullah Özkaya, et al.
Published: (2017-05-01)

Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources
by: Vincent Daien, et al.
Published: (2019-10-01)

Profile of patients receiving intravitreal anti-vascular endothelial growth factor injections during COVID-19-related lockdown
by: Manavi D Sindal, et al.
Published: (2021-01-01)

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy
by: Wallsh J, et al.
Published: (2016-05-01)

Prevalence, Pattern and Risk Factors of Retinal Diseases Among an Elderly Population in Nepal: The Bhaktapur Retina Study
by: Thapa R, et al.
Published: (2020-07-01)

Branch Retinal Vein Occlusion, Macular Ischemia, and Intravitreal Anti-VEGF Therapy
by: Thomas Bertelmann, et al.
Published: (2017-04-01)

Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
by: Wallsh J, et al.
Published: (2020-10-01)

Meta-analysis of anti-VEGF drugs combined steroids for macular edema secondary to retinal vein occlusion
by: Zhuang Hao, et al.
Published: (2021-01-01)

A Multicenter, Cross-Sectional Study of the Incidence of Major Macular Diseases That Cause Visual Impairment and Require Therapeutic Intervention in Greece: The ADVICE Study
by: Karagiannis DA, et al.
Published: (2020-05-01)

Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study
by: Callizo J, et al.
Published: (2019-11-01)

Low health literacy levels in patients with chronic retinal disease
by: Sofie Jandorf, et al.
Published: (2019-08-01)

Study on the change of retinal thickness and choroidal thickness and correlative factors for macular edema after Ranibizumab injection
by: Guan-Lu Liang, et al.
Published: (2018-05-01)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
by: Laine I, et al.
Published: (2017-11-01)

Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
by: Osama A. Sorour, et al.
Published: (2020-06-01)

Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion–related macular edema: A systematic review and meta-analysis of randomized controlled trials
by: Qiuming Hu, et al.
Published: (2019-01-01)

Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
by: Lixiong Gao, et al.
Published: (2019-01-01)

Intraocular Injection of StivantⓇ (A Biosimilar to Bevacizumab): A Case Series
by: Ahmad Mirshahi, et al.
Published: (2021-01-01)

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
by: Singer MA, et al.
Published: (2016-12-01)

Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
by: Tianqin Wang, et al.
Published: (2021-04-01)

Farklı etyolojilere bağlı maküler ödem tedavisinde deksametazon implantın etkinliği
by: Emrah Öztürk, et al.
Published: (2020-06-01)

Characteristics of Somatic Status and Individual Biochemical Markers in Patients with Retinal Vein Occlusion
by: I. V. Zlobin, et al.
Published: (2019-08-01)

Anti-Tumor Necrosis Factor Alpha for Retinal Diseases: Current Knowledge and Future Concepts
by: Alireza Mirshahi, et al.
Published: (2012-01-01)

Clinical efficacy of compound anisodine injection combined with anti-VEGF in the treatment of macular edema due to branch retinal vein occlusion
by: Hui Gao, et al.
Published: (2019-02-01)

Safety and efficacy of Razumab – The new biosimilar in India: Our experience
by: V V Sameera, et al.
Published: (2016-01-01)

Bilateral Hypertensive Retinopathy Complicated with Retinal Neovascularization: Panretinal Photocoagulation or Intravitreal Anti-VEGF Treatment
by: Odysseas Georgiadis, et al.
Published: (2014-07-01)

Effect of Conbercept on retinal vascular density in patients with RVO secondary macular edema
by: Jin Li, et al.
Published: (2019-09-01)

Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab
by: Kerr Brogan, et al.
Published: (2018-02-01)

Microvascular comparison in younger and older patients with retinal vein occlusion analyzed by OCT angiography
by: Panpan Ye, et al.
Published: (2021-04-01)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
by: Sivaprasad S, et al.
Published: (2016-05-01)

Effects of different does intravitreous triamcinolone acetonide for macular edema secondary to retinal vein occlusion
by: Jing Su, et al.
Published: (2018-08-01)

Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
by: Kabanarou SA, et al.
Published: (2017-05-01)

Papillary Vessel Density Changes after Intravitreal Anti-VEGF Injections in Hypertensive Patients with Central Retinal Vein Occlusion: An Angio-OCT Study
by: Michele Nicolai, et al.
Published: (2019-10-01)

Efficacy and safety of Ziv-aflibercept in patients with central retinal vein occlusion
by: Amin E Nawar, et al.
Published: (2021-01-01)

Efficacy observation on multiple wave length laser for diabetic retinopathy and central retinal vein occlusion
by: Tao Tian, et al.
Published: (2014-07-01)

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
by: Levin AM, et al.
Published: (2017-01-01)

Intravitreal injection of anti-vascular endothelial growth factor agents for ocular vascular diseases: Clinical practice guideline
by: Homayoun Nikkhah, et al.
Published: (2018-01-01)

Clinical analysis on diabetic retinopathy combined with retinal vein obstruction
by: Tao Tian, et al.
Published: (2013-08-01)

The Impact of Hyperglycemia on VEGF Secretion in Retinal Endothelial Cells
by: Caprnda Martin, et al.
Published: (2017-06-01)

Effects of the COVID-19 Pandemic on Anti-vascular Endothelial Growth Factor Treatment in China
by: Kai-Bo Yang, et al.
Published: (2020-12-01)

Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery
by: Konstantinos Andreanos, et al.
Published: (2017-12-01)